Also categorized in BoardMoves:
Pandora Jewelry Names New CEO and Board Chairman
x hide permanently

Aurinia Pharmaceuticals (AUPH) Appoints Dr. Daniel Billen to Board

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced it has appointed Dr. Daniel Billen to its Board of Directors. Dr. Billen’s appointment is effective April 29, 2019 concurrent with the previously announced appointment of Mr. Peter Greenleaf as Chief Executive Officer and elevation of Dr. George Milne to Chairman of the Board...

Mentions: Nasdaq Aurinia Pharmaceuticals Dr. Daniel Billen